Mediqventures
Mediqventures is a venture capital firm based in Douglas, Isle of Man, that focuses on investments in the life sciences sector. The firm targets both early and late-stage companies, particularly those developing therapeutic assets related to metabolic diseases, oncology, and infectious diseases. In addition to providing equity financing, Mediqventures supports its portfolio companies by connecting them with a network of drug-development professionals who offer expertise in areas such as discovery programs, finance, and preclinical development. The firm's approach combines financial backing with strategic guidance to foster the growth of innovative biotech ventures.
Top Regions
3 past transactions
Causeway Therapeutics
Venture Round in 2023
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, dedicated to developing novel microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its key products include EquiMiR, a treatment for equine tendinopathy that mimics natural microRNA with enhanced pharmacological properties, and TenoMiR, which restores critical microRNA levels to improve tendon strength and facilitate recovery. By targeting the molecular mechanisms underlying tendon damage and tendinopathy, Causeway Therapeutics aims to provide advanced therapeutic solutions that alleviate pain and promote faster healing for patients suffering from musculoskeletal diseases.
Beckley Psytech
Series A in 2020
Founded in 2014, Beckley Psytech is a UK-based company dedicated to developing psychedelic medicines for treating mental health disorders. It focuses on rigorous scientific research and clinical-stage drug development, aiming to provide innovative treatments for conditions like depression and anxiety.
Causeway Therapeutics
Seed Round in 2017
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, dedicated to developing novel microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its key products include EquiMiR, a treatment for equine tendinopathy that mimics natural microRNA with enhanced pharmacological properties, and TenoMiR, which restores critical microRNA levels to improve tendon strength and facilitate recovery. By targeting the molecular mechanisms underlying tendon damage and tendinopathy, Causeway Therapeutics aims to provide advanced therapeutic solutions that alleviate pain and promote faster healing for patients suffering from musculoskeletal diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.